why choose us

First received: April 18, 2023

Clinical Trial: Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure

Study Type: OBSERVATIONAL


Official Title: Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence. A Post-Market Registry With the Barostim™ System

Brief Summary: The purpose of this study is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients that are symptomatic despite having received CRT.

Read more